v3.26.1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance, Beginning at Dec. 31, 2024 $ 9 $ 837,363 $ 420 $ (378,576) $ 459,216
Balance, Beginning (in shares) at Dec. 31, 2024 94,838,466        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   2,261     2,261
Exercise of stock options (shares) 367,217        
Stock-based compensation   9,059     9,059
Other comprehensive loss     (19)   (19)
Net loss       (40,798) (40,798)
Balance, Ending at Mar. 31, 2025 $ 9 848,683 401 (419,374) 429,719
Balance, Ending (in shares) at Mar. 31, 2025 95,205,683        
Balance, Beginning at Dec. 31, 2024 $ 9 837,363 420 (378,576) 459,216
Balance, Beginning (in shares) at Dec. 31, 2024 94,838,466        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (76,913)
Balance, Ending at Jun. 30, 2025 $ 10 1,044,346 204 (455,489) 589,071
Balance, Ending (in shares) at Jun. 30, 2025 105,341,296        
Balance, Beginning at Mar. 31, 2025 $ 9 848,683 401 (419,374) 429,719
Balance, Beginning (in shares) at Mar. 31, 2025 95,205,683        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of offering costs $ 1 187,100     187,101
Issuance of common stock, net of offering costs (in shares) 9,935,419        
Exercise of stock options and vesting of restricted stock units   233     233
Exercise of stock options and vesting of restricted stock units (in shares) 151,535        
Purchase of common stock under Employee Stock Purchase Plan   597     597
Purchase of common stock under Employee Stock Purchase Plan (in shares) 48,659        
Stock-based compensation   7,733     7,733
Other comprehensive loss     (197)   (197)
Net loss       (36,115) (36,115)
Balance, Ending at Jun. 30, 2025 $ 10 1,044,346 204 (455,489) 589,071
Balance, Ending (in shares) at Jun. 30, 2025 105,341,296        
Balance, Beginning at Dec. 31, 2025 $ 10 1,067,941 677 (546,371) $ 522,257
Balance, Beginning (in shares) at Dec. 31, 2025 106,249,579       106,249,579
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   12,173     $ 12,173
Exercise of stock options (shares) 1,231,943        
Stock-based compensation   8,715     8,715
Other comprehensive loss     (929)   (929)
Net loss       (49,013) (49,013)
Balance, Ending at Mar. 31, 2026 $ 10 1,088,829 (252) (595,384) 493,203
Balance, Ending (in shares) at Mar. 31, 2026 107,481,522        
Balance, Beginning at Dec. 31, 2025 $ 10 1,067,941 677 (546,371) $ 522,257
Balance, Beginning (in shares) at Dec. 31, 2025 106,249,579       106,249,579
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         $ (106,340)
Balance, Ending at Jun. 30, 2026 $ 10 1,101,278 (500) (652,711) $ 448,077
Balance, Ending (in shares) at Jun. 30, 2026 107,776,380       107,776,380
Balance, Beginning at Mar. 31, 2026 $ 10 1,088,829 (252) (595,384) $ 493,203
Balance, Beginning (in shares) at Mar. 31, 2026 107,481,522        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and vesting of restricted stock units   2,294     2,294
Exercise of stock options and vesting of restricted stock units (in shares) 234,659        
Purchase of common stock under Employee Stock Purchase Plan   793     793
Purchase of common stock under Employee Stock Purchase Plan (in shares) 60,199        
Stock-based compensation   9,362     9,362
Other comprehensive loss     (248)   (248)
Net loss       (57,327) (57,327)
Balance, Ending at Jun. 30, 2026 $ 10 $ 1,101,278 $ (500) $ (652,711) $ 448,077
Balance, Ending (in shares) at Jun. 30, 2026 107,776,380       107,776,380